Clinical Research Directory
Browse clinical research sites, groups, and studies.
Psilocybin-facilitated Treatment for Cocaine Use
Sponsor: University of Alabama at Birmingham
Summary
The primary purpose of this study is to evaluate the feasibility and estimate the efficacy of psilocybin-facilitated treatment for cocaine use. We also will monitor the impact of psilocybin-facilitated treatment on the use of other drugs and outcomes relevant to cocaine involvement. MRI assessment is a unique aspect of this study. As a potential biological mechanism of psilocybin's effect includes changes in default mode network functional connectivity (Carhart-Harris et al., 2012), we will determine if psilocybin's therapeutic effects are mediated by such changes. Moreover, as Glx (a brain metabolite that reflects glutamate) abnormalities have been shown to play a role in cocaine addiction, we will determine if psilocybin impacts Glx in the anterior cingulate cortex and hippocampus.
Key Details
Gender
All
Age Range
25 Years - Any
Study Type
INTERVENTIONAL
Enrollment
40
Start Date
2015-05
Completion Date
2024-05
Last Updated
2026-05-18
Healthy Volunteers
No
Conditions
Interventions
Psilocybin
this has been used in treating obsessive-compulsive disorders, cluster headaches, anxiety, and drug dependence.
Diphenhydramine
This drug will be used as the control. Diphenhydramine is a histamine blocker.
Locations (1)
UAB Outpatient Clinical Research Unit
Birmingham, Alabama, United States